Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

by Dubinsky, Marla C., Rosh, Joel, Faubion, William A., Kierkus, Jaroslaw, Ruemmele, Frank, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Huang, Bidan, Mostafa, Nael M., Lazar, Andreas, Thakkar, Roopal B.
Published 2016

Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial

by Panaccione, Remo, Sandborn, William J., Gordon, Glenn L., Lee, Scott D., Safdi, Alan, Sedghi, Shahriar, Feagan, Brian G., Hanauer, Stephen, Reinisch, Walter, Valentine, John F., Huang, Bidan, Carcereri, Roberto
Published 2015

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

by Colombel, Jean-Frederic, Sandborn, William J, Ghosh, Subrata, Wolf, Douglas C, Panaccione, Remo, Feagan, Brian, Reinisch, Walter, Robinson, Anne M, Lazar, Andreas, Kron, Martina, Huang, Bidan, Skup, Martha, Thakkar, Roopal B
Published 2014